$32.455
+0.461 (+1.42%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
CAI-Prognose durch Analyse ähnlicher Charts
Alphio's CAI stock price prediction model matches the current Caris Life Sciences, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $33.29 (+2.57%). The 1-week path is $32.80 (+1.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Caris Life Sciences, Inc.-Aktien kaufen?
Caris Life Sciences Inc is a good buy right now due to its current price of $32, which is supported by a strong gross margin of 68.10% in Q2 2026 and a forward P/E ratio of 43.29. The company has shown impressive revenue growth, with a 45.4% year-over-year increase in Q2 2026 revenue to $263.7 million, indicating strong market demand. However, the main risk is the high P/E ratio of 85.68, which suggests that the stock may be overvalued if growth expectations are not met.
CAI schloss am Monday bei $32.46, nachdem der Kurs +1.42% gestiegen ist
Caris Life Sciences, Inc. (CAI) last closed at $32.4550018, gaining +1.42%. These facts feed the 1-day and 1-week CAI price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Caris Life Sciences, Inc. (CAI) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf CAI am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für CAI
Historically the probability of a positive October return for CAI is 100.00%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.